nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer
|
Hussain, Maha |
|
2015 |
51 |
13 |
p. 1714-1724 11 p. |
artikel |
2 |
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma
|
Davis, Elizabeth J. |
|
2015 |
51 |
13 |
p. 1794-1802 9 p. |
artikel |
3 |
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study
|
Pivot, Xavier |
|
2015 |
51 |
13 |
p. 1660-1666 7 p. |
artikel |
4 |
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease
|
Lamarca, Angela |
|
2015 |
51 |
13 |
p. 1694-1703 10 p. |
artikel |
5 |
Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease
|
Orsini, Ricardo G. |
|
2015 |
51 |
13 |
p. 1675-1682 8 p. |
artikel |
6 |
Differences in cancer drug assessment between Spain and the United Kingdom
|
Lozano-Blázquez, Ana |
|
2015 |
51 |
13 |
p. 1843-1852 10 p. |
artikel |
7 |
Duration of Trastuzumab. In matters of the heart, one size may not fit all?
|
Simmons, Christine |
|
2015 |
51 |
13 |
p. 1657-1659 3 p. |
artikel |
8 |
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone
|
Vincent, Julie |
|
2015 |
51 |
13 |
p. 1683-1693 11 p. |
artikel |
9 |
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma
|
Tejera-Vaquerizo, Antonio |
|
2015 |
51 |
13 |
p. 1780-1793 14 p. |
artikel |
10 |
Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens
|
Rocha, Luis B. |
|
2015 |
51 |
13 |
p. 1822-1830 9 p. |
artikel |
11 |
Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases
|
Bolze, Pierre-Adrien |
|
2015 |
51 |
13 |
p. 1725-1731 7 p. |
artikel |
12 |
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
|
Serrano, Beatriz |
|
2015 |
51 |
13 |
p. 1732-1741 10 p. |
artikel |
13 |
Hypocalcaemia in patients with metastatic bone disease treated with denosumab
|
Body, Jean-Jacques |
|
2015 |
51 |
13 |
p. 1812-1821 10 p. |
artikel |
14 |
Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic review
|
Li, Xiaoqi |
|
2015 |
51 |
13 |
p. 1751-1759 9 p. |
artikel |
15 |
Management of breast cancer after Hodgkin’s lymphoma and paediatric cancer
|
Terenziani, M. |
|
2015 |
51 |
13 |
p. 1667-1674 8 p. |
artikel |
16 |
Molecular changes in endometriosis-associated ovarian clear cell carcinoma
|
Worley Jr., Michael J. |
|
2015 |
51 |
13 |
p. 1831-1842 12 p. |
artikel |
17 |
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system
|
You, Rui |
|
2015 |
51 |
13 |
p. 1771-1779 9 p. |
artikel |
18 |
PD-L1 expression in small cell lung cancer
|
Komiya, Takefumi |
|
2015 |
51 |
13 |
p. 1853-1855 3 p. |
artikel |
19 |
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials
|
Peeters, M. |
|
2015 |
51 |
13 |
p. 1704-1713 10 p. |
artikel |
20 |
Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma
|
Preusser, Matthias |
|
2015 |
51 |
13 |
p. 1803-1811 9 p. |
artikel |
21 |
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials
|
Bosse, Tjalling |
|
2015 |
51 |
13 |
p. 1742-1750 9 p. |
artikel |
22 |
Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area
|
Huang, Pei-Yu |
|
2015 |
51 |
13 |
p. 1760-1770 11 p. |
artikel |